AIDS Vaccine

Study Suggests Possibility Of Universally Effective AIDS Vaccine

Published in AIDS Weekly, November 17th, 1997

A study by a research team based at the Massachusetts General Hospital (MGH) suggests that it may be possible to develop an AIDS vaccine that will be effective against the different versions of the causal virus, HIV, found around the world.

As reported in the November 1997 issue of the Journal of Virology, the researchers found that the immune system's killer cells, called cytotoxic T-lymphocytes (CTLs), are capable of recognizing different strains, or clades, of the human immunodeficiency virus (HIV). In the past, it had been feared that the prevalence of different HIV strains in different parts of the world would require developing different vaccines targeted to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1997-11-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry